Allarity Therapeutics Inc Share Price Today: Live Updates & Key Insights

Allarity Therapeutics Inc share price today is $1.08, up -1.82%. The stock opened at $1.09 against the previous close of $1.1, with an intraday high of $1.11 and low of $1.05.

Allarity Therapeutics Inc Share Price Chart

Allarity Therapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Allarity Therapeutics Inc Share Price Performance

$1.08 -0.0182(-1.82%) ALLR at 23 Mar 2026 11:58 AM Biotechnology
Lowest Today 1.05
Highest Today 1.11
Today’s Open 1.09
Prev. Close 1.1
52 Week High 2.06
52 Week Low 0.61
Day’s Range: Low 1.05 High 1.11
52-Week Range: Low 0.61 High 2.06
1 day return -
1 Week return -13.49
1 month return +14.18
3 month return +11.21
6 month return -38.41
1 year return +7.92
3 year return -99.96
5 year return -99.99
10 year return -

Allarity Therapeutics Inc Institutional Holdings

Renaissance Technologies Corp 1.54

Vanguard Group Inc 1.53

Vanguard Institutional Extnd Mkt Idx Tr 1.07

Geode Capital Management, LLC 0.97

State Street Corp 0.86

Capital Advisors, Inc. 0.62

Fidelity Extended Market Index 0.54

Citadel Advisors Llc 0.53

Private Advisor Group, LLC 0.35

Northern Trust Corp 0.27

NT Ext Equity Mkt Idx Fd - NL 0.18

Two Sigma Investments LLC 0.17

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.14

Fidelity Total Market Index 0.14

Fidelity Series Total Market Index 0.13

Spartan Extended Market Index Pool F 0.11

TWO SIGMA SECURITIES, LLC 0.08

HRT FINANCIAL LLC 0.06

Spartan Total Market Index Pool G 0.06

NT US Market Cap Idx Fd - L 0.00

Bank of America Corp 0.00

Advisor Group Holdings, Inc. 0.00

Citigroup Inc 0.00

Danske Bank A/S. 0.00

Jane Street Group LLC 0.00

Squarepoint Ops LLC 0.00

Tower Research Capital LLC 0.00

UBS Group AG 0.00

XTX Topco Ltd 0.00

Allarity Therapeutics Inc Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Allarity Therapeutics Inc Fundamentals

Market Cap 17.28 M

PB Ratio 1.4326

PE Ratio 0.207

Enterprise Value 1.70 M

Total Assets 22.65 M

Volume 177204

Allarity Therapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:120000 0.1M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:120000 0.1M

Annual Net worth FY23:-13017000 -13.0M, FY22:-16058000 -16.1M, FY21:-26648000 -26.6M, FY20:-5073000 -5.1M, FY19:-14400000 -14.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-12000 -0.0M, Q1/2025:-11000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-1000 -0.0M

Quarterly Net worth Q3/2025:-2806000 -2.8M, Q2/2025:-2320000 -2.3M, Q1/2025:-2732000 -2.7M, Q3/2024:-12152000 -12.2M, Q2/2024:-1629000 -1.6M

About Allarity Therapeutics Inc & investment objective

Company Information Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2 clinical trial in patients with advanced and recurrent ovarian cancer. The company also develops stenoparib- DRP, a companion diagnostic product used in select patients for stenoparib treatment. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Organisation Biotechnology

Employees 6

Industry Biotechnology

CEO Mr. Thomas H. Jensen

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Allarity Therapeutics Inc FAQs

What is the share price of Allarity Therapeutics Inc today?

The current share price of Allarity Therapeutics Inc is $1.08.

Can I buy Allarity Therapeutics Inc shares in India?

Yes, Indian investors can buy Allarity Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Allarity Therapeutics Inc shares in India?

You can easily invest in Allarity Therapeutics Inc shares from India by:

Can I buy fractional shares of Allarity Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Allarity Therapeutics Inc?

Allarity Therapeutics Inc has a market cap of $17.28 M.

In which sector does Allarity Therapeutics Inc belong?

Allarity Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Allarity Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Allarity Therapeutics Inc?

The PE ratio of Allarity Therapeutics Inc is 0.21 and the PB ratio is 1.43.